Threat Detection Company's AI Division Partners with Healthcare Firm to Increase Cancer Testing Access
Source: Streetwise Reports  (7/16/20)
Patriot One Technologies reported its Xtract AI division is working with Canexia Health to increase access to cancer testing as part of the Digital Technology Supercluster COVID-19 Program project. More >

AC Immune Shares Rise 19% as Firm Advances Alzheimer's Vaccine in Phase 1b/2a Trial
Source: Streetwise Reports  (7/16/20)
AC Immune SA shares set a new 52-week high after the Swiss biotech firm reported that interim data from its Phase 1b/2a phospho-Tau Alzheimer's Vaccine study reconfirms promising safety and Tau-specific immunogenicity observed in the prior clinical trial. More >

Taiwan Liposome Shares Rise 60% on Inhalable Liposomal HCQ Potential Covid-19 Treatment Claims
Source: Streetwise Reports  (7/15/20)
Shares of Taiwan Liposome Co. reached a new 52-week high after the company released a manuscript describing how its inhalable liposomal hydroxychloroquine may provide clinical benefit and offer a potential treatment for Covid-19. More >

Virtual Healthcare Tech Firm's Contract in Puerto Rico Is Its Largest by 400%
Source: Streetwise Reports  (7/15/20)
Reliq Health Technologies' agreement with digiiMED makes its platform available to more than 200,000 patients. More >

Potential Covid-19 Treatment Is Ready for Prime Time
Source: Streetwise Reports  (7/14/20)
Small-cap Algernon Pharmaceuticals is about to begin a multinational Phase 2b/3 trial for Ifenprodil, a repurposed drug with a known safety record. More >

INmune Bio Shares Double after Reporting Positive Phase 1b Alzheimer's Trial Data
Source: Streetwise Reports  (7/14/20)
Shares of INmune Bio reached a new 52-week high after the company reported interim data from its Phase 1b study of XPro1595 that demonstrated decreased neuroinflammation in Alzheimer's patients. More >

Analyst: Integrated Model Positioned to Monetize on Telehealth Emergence
Source: Streetwise Reports  (7/13/20)
Echelon Capital Markets initiates coverage and explains why it is bullish on CloudMD Software & Services. More >

Biotech Partners to Develop, Offer Alzheimer's Disease Tests
Source: Streetwise Reports  (7/13/20)
ProMIS Neurosciences and its collaborator make their relationship official with a joint venture agreement. More >

BioNTech Shares Rise as FDA Grants It and Partner Pfizer Fast Track Status for Two Covid-19 Vaccine Candidates
Source: Streetwise Reports  (7/13/20)
Shares of BioNTech SE traded 15% higher after the company reported that, together with its partner Pfizer, it has received FDA Fast Track designation for two separate mRNA-based vaccine candidates against SARS-CoV-2. More >

Threat Detection Company Forms Partnership to Advance Covid-19 Pathogen Screening
Source: Streetwise Reports  (7/12/20)
Patriot One Technologies reported it is collaborating with ecoMine Technologies to advance pathogen screening applications as part of Canada's Digital Technology Supercluster's Covid-19 program. More >

Altimmune Shares Up 20% Upon Forming Partnership for Intranasal COVID-19 Vaccine
Source: Streetwise Reports  (7/9/20)
Altimmune shares reached a new 52-week high after the company reported it is collaborating with DynPort Vaccine on U.S. government funding efforts for AdCOVID™, its COVID-19 vaccine candidate. More >

Biotech with Phase 3 Rheumatoid Arthritis and Psoriasis Trials Raises Capital, Now 'Funded Through Catalysts'
Source: Streetwise Reports  (7/8/20)
An update on Can-Fite BioPharma's multiple drug treatment trials is provided in a Dawson James report. More >

Preclinical COVID-19 Vaccine Data 'Encouraging'
Source: Streetwise Reports  (7/8/20)
Updates on Sorrento Therapeutics' two coronavirus-related products are provided in an H.C. Wainwright & Co. report. More >

Biopharma Starts Enrollment Screening for Phase 2 Pulmonary Fibrosis, Cough Trial
Source: Streetwise Reports  (7/8/20)
In the study, Algernon Pharmaceuticals will test an existing drug that is being repurposed for these indications. More >

Analyst: G1 Minimizes the Carnage of Chemotherapy
Source: Streetwise Reports  (7/1/20)
ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA. More >

'Undervalued' Biopharma Gets Breakthrough Status for Alzheimer's Agitation Drug
Source: Streetwise Reports  (7/1/20)
Axsome Therapeutics' latest news and clinical outlook are discussed in an H.C. Wainwright & Co. report. More >

Life Sciences Firm Submits IND Application to FDA for Phase 3 COVID-19 Study
Source: Streetwise Reports  (7/1/20)
Revive Therapeutics submitted an Investigational New Drug Application to the FDA for a Phase 3 confirmatory study of Bucillamine for treatment in SARS-CoV-2. More >

Akero Therapeutics Shares Rise on Positive Data from Phase 2a NASH Study
Source: Streetwise Reports  (7/1/20)
Akero Therapeutics shares traded 28% higher and established a new 52-week high after the company reported that it recorded positive histological data across all Efruxifermin dosage groups in its Phase 2a BALANCED Study in NASH patients. More >

Biopharma's Multinational COVID-19 Study Receives US Ethics Approval
Source: Streetwise Reports  (6/30/20)
Algernon Pharmaceuticals is seeking approved participation from Australia, Romania and the Philippines as well. More >

Life Sciences Firm Gains Approval to Sell Non-Antibiotic Livestock Feed Additive in Brazil
Source: Streetwise Reports  (6/25/20)
Avivagen reported it received approval for use of OxC-beta™ Livestock in Brazil and it has signed an agreement with a São Paulo company for distribution. More >

Vaxart Shares Rise 95% After Signing Agreement for Oral Tablet COVID-19 Vaccine
Source: Streetwise Reports  (6/25/20)
Shares of Vaxart Inc. nearly doubled after the company reported that it has signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow to enable production of a billion or more tablet COVID-19 vaccine doses annually. More >

Biotech's New Mesothelioma Trial Data Show Efficacy, Immunogenicity
Source: Streetwise Reports  (6/24/20)
These results of a study evaluating Targovax's lead candidate are reviewed and commented on in an H.C. Wainwright & Co. report. More >

Telemedicine Firm to Acquire Majority Interest in Ontario Clinic
Source: Streetwise Reports  (6/23/20)
With this transaction, CloudMD Software & Services expands its size and reach. More >

Translate Bio and Sanofi Expand Partnership to Develop mRNA Vaccines
Source: Streetwise Reports  (6/23/20)
Translate Bio shares traded 45% higher reaching a new 52-week high after the company reported that it is expanding its collaboration with Sanofi Pasteur to develop mRNA vaccines across all infectious disease areas. More >

Invitae Corp. Enters into Definitive Agreement to Acquire ArcherDX
Source: Streetwise Reports  (6/22/20)
Shares of Invitae Corp. traded 40% higher after the company reported it will acquire ArcherDX in a combination cash and stock deal valued at around $1.4 billion. More >